Grufity logo
Grufity logo

Latest SUVRETTA CAPITAL MANAGEMENT, LLC Stock Portfolio

$5.47Billion | No. of Holdings #95

SUVRETTA CAPITAL MANAGEMENT, LLC Performance

2026 Q2+22.18%
YTD+17.63%
2025+22.41%

About SUVRETTA CAPITAL MANAGEMENT, LLC and 13F Hedge Fund Stock Holdings

SUVRETTA CAPITAL MANAGEMENT, LLC is a hedge fund based in New York, NY. On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, SUVRETTA CAPITAL MANAGEMENT, LLC reported an equity portfolio of $5.5 Billions as of 30 Jun, 2026. <br><br> The top stock holdings of SUVRETTA CAPITAL MANAGEMENT, LLC are , ARQT, LEGN. The fund has invested 9.4% of it's portfolio in VERADERMICS INC and 6% of portfolio in ARCUTIS BIOTHERAPEUTICS INC. <br><br> The fund managers got completely rid off APELLIS PHARMACEUTICALS INC (APLS), KALVISTA PHARMACEUTICALS INC (KALV) and ERASCA INC (ERAS) stocks. They significantly reduced their stock positions in US FOODS HLDG CORP (USFD), PERFORMANCE FOOD GROUP CO (PFGC) and MINERALYS THERAPEUTICS INC. SUVRETTA CAPITAL MANAGEMENT, LLC opened new stock positions in AVALYN PHARMACEUTICALS INC, AMPHENOL CORP (APH) and DICKS SPORTING GOODS INC (DKS). The fund showed a lot of confidence in some stocks as they added substantially to SPOTIFY TECHNOLOGY S A (SPOT), FAETH THERAPEUTICS INC (SNSE) and LEXEO THERAPEUTICS INC.
SUVRETTA CAPITAL MANAGEMENT, LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$5.47Billion
  as of Aug 14, 2026

SUVRETTA CAPITAL MANAGEMENT, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that MONTANOVA CAPITAL, LLC made a return of 22.18% in the last quarter. In trailing 12 months, it's portfolio return was 48.3%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
avalyn pharmaceuticals inc82,402,400
hut 8 corp77,348,200
amphenol corp47,483,000
roundhill etf trust44,531,600
cerebras systems inc37,989,900
dicks sporting goods inc34,320,900
broadcom inc31,579,900
space exploration techn corp17,291,000
New stocks bought by SUVRETTA CAPITAL MANAGEMENT, LLC

Additions

Ticker% Inc.
spotify technology s a9,154
faeth therapeutics inc5,747
lexeo therapeutics inc410
dexcom inc221
inflarx nv189
aura biosciences inc64.79
nvidia corporation25.4
sysco corp21.77
Additions to existing portfolio by SUVRETTA CAPITAL MANAGEMENT, LLC

Reductions

Ticker% Reduced
us foods hldg corp-98.25
performance food group co-96.2
mineralys therapeutics inc-88.7
abeona therapeutics inc-81.32
johnson & johnson-67.09
fulcrum therapeutics inc-43.9
bank of amer corp-39.03
unitedhealth group inc-36.27
SUVRETTA CAPITAL MANAGEMENT, LLC reduced stake in above stock

Sold off

Ticker$ Sold
kalvista pharmaceuticals inc-95,994,200
apellis pharmaceuticals inc-141,548,000
erasca inc-55,577,800
kezar life sciences inc-5,318,350
life time group holdings inc-13,748,800
medtronic plc-6,261,330
wingstop inc-9,220,720
coherent corp-7,146,300
SUVRETTA CAPITAL MANAGEMENT, LLC got rid off the above stocks

Sector Distribution

MONTANOVA CAPITAL, LLC has about 44.6% of it's holdings in Others sector.

  • Others
  • Healthcare
  • Technology
  • Consumer Cyclical
  • Communication Services
  • Industrials
  • Consumer Defensive
  • Financial Services
  • Basic Materials
Sector%
Others44.6
Healthcare29.1
Technology7.9
Consumer Cyclical6
Communication Services3.1
Industrials2.7
Consumer Defensive2.5
Financial Services2.3
Basic Materials1.6

Market Cap. Distribution

MONTANOVA CAPITAL, LLC has about 27.5% of it's portfolio invested in the large-cap and mega-cap stocks.

  • UNALLOCATED
  • MEGA-CAP
  • SMALL-CAP
  • LARGE-CAP
  • MID-CAP
  • NANO-CAP
Category%
UNALLOCATED45.6
MEGA-CAP16.3
SMALL-CAP14.4
LARGE-CAP11.2
MID-CAP11.2
NANO-CAP1.1

Stocks belong to which Index?

About 47.6% of the stocks held by MONTANOVA CAPITAL, LLC either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • S&P 500
  • RUSSELL 2000
Index%
Others52.4
S&P 50025.9
RUSSELL 200021.7
Top 5 Winners (%)%
AMD
advanced micro devices inc
185.6 %
veradermics inc
94.7 %
anteris technologies global
77.5 %
biohaven ltd
75.9 %
IFRX
inflarx nv
67.9 %
Top 5 Winners ($)$
veradermics inc
249.3 M
AMD
advanced micro devices inc
97.1 M
LEGN
legend biotech corp
79.0 M
biohaven ltd
66.0 M
arrivent biopharma inc
52.0 M
Top 5 Losers (%)%
CMPX
compass therapeutics inc
-58.2 %
FULC
fulcrum therapeutics inc
-40.8 %
BSX
boston scientific corp
-30.7 %
CAPR
capricor therapeutics inc
-20.2 %
HCA
hca healthcare inc
-17.6 %
Top 5 Losers ($)$
CMPX
compass therapeutics inc
-44.0 M
CAPR
capricor therapeutics inc
-25.0 M
FULC
fulcrum therapeutics inc
-20.5 M
SNSE
faeth therapeutics inc
-6.7 M
lexeo therapeutics inc
-4.1 M

SUVRETTA CAPITAL MANAGEMENT, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of SUVRETTA CAPITAL MANAGEMENT, LLC

MONTANOVA CAPITAL, LLC has 95 stocks in it's portfolio. About 38.8% of the portfolio is in top 10 stocks. CMPX proved to be the most loss making stock for the portfolio. was the most profitable stock for MONTANOVA CAPITAL, LLC last quarter.

$4.76BTotal Value
109Positions
14 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of SUVRETTA CAPITAL MANAGEMENT, LLC, last reported on 14 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
ACT
Advisorshares Tr

Advisorshares Tr

ACT
SUVRETTA CAPITAL MANAGEMENT, LLC's holding in Advisorshares Tr over time
0.9%9,738,520
$49.47M
0.9%
increased 7.65 percentadded